The co-primary outcomes were changes in body weight and the Knee Injury and Osteoarthritis Outcome Score pain subscale from week 0 to 52 [47, 48]
Common adverse effects of GLP-1 receptor agonists include: Gastrointestinal symptoms : Nausea, vomiting, diarrhoea, constipation, and abdominal pain affect 30-50% of users, typically improving over time [20] Injection site reactions : Redness, itching, or discomfort at injection sites Gallbladder problems : Increased risk of cholelithiasis (gallstones) and cholecystitis Pancreatitis : Rare but serious risk requiring immediate medical attention if severe abdominal pain develops Hypoglycemia : Particularly when combined with other diabetes medications Additional important safety considerations include avoiding use during pregnancy and breastfeeding, risk of dehydration and acute kidney injury, and potential worsening of diabetic retinopathy in people with diabetes
Is There a Generic Semaglutide Version of Ozempic, Wegovy, and Rybelsus
British journal of haematology
Manufacturing occurs in the United States under FDA-compliant conditions